A large amount of knowledge has been acquired since the original descriptions of Lyme
borreliosis (LB) and of its causative agent, Borrelia burgdorferi sensu stricto. The complexity of …

This evidence-based clinical practice guideline for the prevention, diagnosis, and treatment
of Lyme disease was developed by a multidisciplinary panel representing the Infectious …

Background It is unclear whether antimicrobial treatment after an Ixodes scapularis tick bite
will prevent Lyme disease. Methods In an area of New York where Lyme disease is …

The recent emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic has posed formidable challenges for clinical laboratories seeking reliable …

We investigated the appearance and evolution of immunoglobulin M (IgM) and IgG antibodies
to Borrelia burgdorferi in 46 patients with culture-proven erythema migrans (EM). All …

BACKGROUND: The diagnosis of erythema migrans (EM), the characteristic rash of early
Lyme borreliosis, is based primarily on its clinical appearance since it often occurs prior to the …

Infection with the agent of human granulocytic ehrlichiosis occurs in areas in which Borrelia
burgdorferi and Babesia microti are endemic. – 4 The most likely vector of human …

Background: The clinical manifestations of Lyme borreliosis in North America and Europe
seem to differ, but a systematic comparison has never been done. Objective: To compare …

Background: Human granulocytic ehrlichiosis (HGE) is a newly described illness with few
reports in the literature. Objective: To describe the clinical and laboratory features of HGE. …

For the diagnosis of Lyme disease, the 2-tier serologic testing protocol for Lyme disease
has a number of shortcomings including low sensitivity in early disease; increased cost, time, …